DDOG vs PFE: Which Is the Better Buy?
Side-by-side comparison of Datadog, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Datadog, Inc. · Technology
$104.77
+55.6% upside to fair value
Grade B
High Quality
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
DDOG has more upside to fair value
(+55.6%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DDOG |
PFE |
| Current Price |
$104.77 |
$26.91 |
| Fair Value Estimate |
$163.01 |
$35.00 |
| Upside to Fair Value |
+55.6%
|
+30.1%
|
| Market Cap |
$37.1B |
$153.0B |
| Forward P/E |
341.2x
|
9.5x
|
| EV / EBITDA |
168.3x
|
13.8x
|
| Price / Sales |
10.8x
|
2.4x
|
| Price / FCF |
37.0x
|
16.8x
|
| Revenue Growth YoY |
+7.6%
|
-1.6%
|
| Gross Margin |
79.9%
|
70.3%
|
| Operating Margin |
-1.3%
|
24.7%
|
| Return on Equity |
3.2%
|
9.0%
|
| Dividend Yield |
0% |
6.4% |
| FCF Yield |
2.7%
|
5.9%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Datadog, Inc. is a leading cloud-based monitoring and analytics platform specializing in observability and security for cloud-native, microservices, and AI applications. The company benefits from strong product-market fit driven by extensive integrations and a customer-centric approach, reflected in 26% revenue growth to $3.43 billion in fiscal 2025 and 37.4% earnings growth year-over-year. Despi…
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
DDOG |
PFE |
| Zone Low |
$122.26 |
$25.00 |
| Zone High |
$138.56 |
$29.00 |
| In Buy Zone? |
Yes
|
Yes
|